Skip to content

Immediate efficacy observation of acupuncture in the treatment of postoperative pain after hip replacement surgery for femoral neck fracture

Immediate efficacy observation of acupuncture in the treatment of postoperative pain after hip replacement surgery for femoral neck fracture

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000459
Enrollment
Unknown
Registered
2025-03-04
Start date
2025-03-31
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain after hip arthroplasty for femoral neck fracture

Interventions

Control Group:Sham acupuncture

Sponsors

Kunming Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Patients with unilateral pain after hip arthroplasty for femoral neck fracture between the ages of 50-75 years old men and women are not limited; 2) Patients with acute pain episodes; 3) Patients with moderate to severe pain (4 points = VAS score = 9 points); 4) No previous history of allergy to opioid analgesic; 5) Able to actively cooperate complete the clinical study and sign the informed consent form. (Note: Patients who also meet the above 5 items can be included in this study.)

Exclusion criteria

Exclusion criteria: 1) patients with multiple fractures or pathological fractures; 2) patients with combination of serious primary diseases such as cardiovascular cerebrovascular hepatic renal hematopoietic systems and other organic diseases or infections coagulation disorders allergies skin diseases etc.; 3) patients with combination of serious anxiety depression insomnia and other mental illnesses or intellectual disabilities who are unable to cooperate with the questionnaires; 4) patients who have already taken analgesic medicines after the operation; 5) patients with malignant tumors; 6) patients who are intolerant of or Patients who are intolerant to acupuncture or allergic to acupuncture needles; 7) Patients who are participating in other programs. (Patients with any one of these conditions cannot be included in this study.)

Design outcomes

Primary

MeasureTime frame
VAS after 10 minutes of needling;

Secondary

MeasureTime frame
blinded evaluation;expected evaluation of treatment effect;VAS at 2, 4, 6, and 8 minutes of patient treatment;Effectiveness;

Countries

China

Contacts

Public ContactLiao jiang long

Kunming Municipal Hospital of Traditional Chinese Medicine

373772123@qq.com15877953130

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026